Role of taurine uptake on the induction of long-term synaptic potentiation

Eur J Neurosci. 2004 Apr;19(7):1875-86. doi: 10.1111/j.1460-9568.2004.03309.x.

Abstract

Taurine application in the CA1 area of rat hippocampal slices induces a long-lasting potentiation of excitatory synaptic transmission that has some mechanistic similitude with the late phase of long-term potentiation (L-LTP). Previous indirect evidence such as temperature and sodium dependence indicated that taurine uptake is one of the primary steps leading to the taurine-induced synaptic potentiation. We show that taurine-induced potentiation is not related to the intracellular accumulation of taurine and is not impaired by 2-guanidinoethanesulphonic acid, a taurine transport inhibitor that is a substrate of taurine transporter. We have found that taurine uptake in hippocampal synaptosomes was inhibited by SKF 89976A, a GABA uptake blocker that is not transportable by GABA transporters. SKF 89976A prevents the induction of synaptic potentiation by taurine application. This effect is neither mimicked by nipecotic acid, a broad inhibitor of GABA transporters that does not affect taurine uptake, nor by NO-711, a specific and potent inhibitor of GABA transporter GAT-1. In addition, L-LTP induced by trains of high-frequency stimulation is also inhibited by SKF 89976A, and taurine, at a concentration that does not change basal synaptic transmission, overcomes such inhibition. We conclude that taurine induces synaptic potentiation through the activation of a system transporting taurine and that taurine uptake is required for the induction of synaptic plasticity phenomena such as L-LTP.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Carrier Proteins / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Postsynaptic Potentials / physiology
  • Female
  • GABA Antagonists / pharmacology
  • Guanidines / pharmacology
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • In Vitro Techniques
  • Intracellular Space / drug effects
  • Long-Term Potentiation / physiology*
  • Membrane Glycoproteins / antagonists & inhibitors
  • Membrane Transport Proteins*
  • Nipecotic Acids / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Synapses / drug effects
  • Synapses / physiology*
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism
  • Taurine / metabolism*

Substances

  • Carrier Proteins
  • Excitatory Amino Acid Antagonists
  • GABA Antagonists
  • Guanidines
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nipecotic Acids
  • taurine transporter
  • Taurine
  • nipecotic acid
  • 2-guanidinoethylphosphonic acid
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 2-Amino-5-phosphonovalerate